TEST REPORT Status : Final

Registration No. : 1056402396 Reg. Date : 28-May-2021 20:20 Collected On : 28-May-2021 20:20
Patient Name : Mr. NIKHIL GOYAL Approved on : 28-May-2021 21:49
Age : 30 Years Gender : Male Dispatch At :
Ref. By : Dr. RASESH DESAI Tele No. : 7600357698
Location : UHID / IPD : /

Test Name Results Units Bio. Ref. Interval

RANDOM GLUCOSE

RANDOM PLASMA GLUCOSE 85 mg/dL >= 200 Suggestive of Diabetes

Method:Glucose Oxidase
Sample Type:Plasma

Note:
If the patient Random Plasma Glucose value is >=200 mg/dL , Advice Oral Glocose Tolerence test (OGTT) for Further Evaluation.
Criteria for the diagnosis of diabetes:
1. HbA1c >/= 6.5 *
Or
2. Fasting plasma glucose >126 gm/dL. Fasting is defined as no caloric intake at least for 8 hrs.
Or
3. Two hour plasma glucose >/= 200mg/dL during an oral glucose tolerence test by using a glucose load containing equivalent of 75 gm anhydrous glucose dissolved in
water.
Or
4. In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose >/= 200 mg/dL.
*In the absence of unequivocal hyperglycemia, criteria 1-3 should be confirmed by repeat testing.
American diabetes association. Standards of medical care in diabetes 2011. Diabetes care 2011;34;S11.

This is an electronically authenticated report. Test done from collected sample.

Approved by: Dr. Ankit Jhaveri

Printed On: 29-May-2021 14:25 MD Pathology
Reg. G-15471
Page 1 of 5
 TEST REPORT Status : Final
Registration No. : 1056402396 Reg. Date : 28-May-2021 20:20 Collected On : 28-May-2021 20:20
Patient Name : Mr. NIKHIL GOYAL Approved on : 29-May-2021 00:27
Age : 30 Years Gender : Male Dispatch At :
Ref. By : Dr. RASESH DESAI Tele No. : 7600357698
Location : UHID / IPD : /

Test Name Results Units Bio. Ref. Interval

HEMOGLOBIN A1 C

HbA1c 5.70 % Normal: <= 5.6

Prediabetes: 5.7-6.4
Diabetes: >= 6.5
Diabetes Control Criteria :
6-7 : Near Normal Glycemia
<7 : Goal
7-8 : Good Control
>8 : Action Suggested
Method:HPLC

Mean Blood Glucose 117 mg/dL

Method:Calculated
Sample Type:Whole Blood

Criteria for the diagnosis of diabetes

1. HbA1c >/= 6.5 *Or
2. Fasting plasma glucose >126 gm/dL. Fasting is defined as no caloric intake at least for 8 hrs.Or
3. Two hour plasma glucose >/= 200mg/dL during an oral glucose tolerence test by using a glucose load containing equivalent of 75 gm anhydrous glucose dissolved in
water.Or
4. In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose  >/= 200 mg/dL. *In the absence of unequivocal hyperglycemia,
criteria 1-3 should be confirmed by repeat testing.American diabetes association. Standards of medical care in diabetes 2011. Diabetes care 2011:34:S11.
Limitation of HbA1c
1) In patients with Hb variants even analytically correct results do not reflect the same level of glycemic control that would be expected in patients with normal
population.
2) Any cause of shortened erythrocyte survival or decreased mean erythrocyte survival or decreased mean erythrocyte age eg. hemolytic diseases, pregnancy, significant 
recent/chronic blood loss etc. will reduce exposure of RBC to glucose with consequent decrease in HbA1c values.
3) Glycated HbF is not detected by this assay and hence specimens containing high HbF (>10%)may result in lower HbA1c values than expected.
Importance of HbA1C (Glycated Hb.) in Diabetes Mellitus
- HbA1C, also known as glycated heamoglobin, is the most important test for the assessment of long term blood glucose control( also called glycemic control).
- HbA1C reflects mean glucose concentration over pas 6-8 weeks and provides a much better indication of longterm glycemic control than blood glucose
determination.
- HbA1c is formed by non-enzymatic reaction between glucose and Hb. This reaction is irreversible and therefore remains unaffected by short term fluctuations
in blood glucose levels.
- Long term complications of diabetes such as retinopathy (Eye-complications), nephropathy (kidney-complications) and neuropathy (nerve complications), are
potentially serious and can lead to blindness, kidney failure, etc.
- Glyemic control monitored by HbA1c measurement using HPLC method (GOLD STANDARD ) is considered most important. (Ref. National Glycohaemoglobin
Standardization Program - NGSP) .

This is an electronically authenticated report. Test done from collected sample.

Approved by: Dr. Vishal Jhaveri

Printed On: 29-May-2021 14:25 M.B.B.S, D.C.P
Reg. G-13041
Page 2 of 5
Bio-Rad CDM System PATIENT REPORT
Bio-Rad Variant V-II Turbo Instrument #1 V2TURBO_A1c_2.0

Patient Data Analysis Data

Sample ID: 11056402396 Analysis Performed: 05/28/2021 23:40:24
Patient ID: Injection Number: 10169
Name: Run Number: 476
Physician: Rack ID: 0003
Sex: Tube Number: 3
DOB: Report Generated: 05/29/2021 00:03:09
Operator ID:
Comments:

NGSP Retention Peak

Peak Name % Area % Time (min) Area
A1a --- 1.4 0.155 21845
A1b --- 1.9 0.217 29055
LA1c --- 1.7 0.389 25981
A1c 5.7 --- 0.488 69604
P3 --- 3.7 0.776 56255
P4 --- 1.3 0.859 20296
Ao --- 85.5 0.998 1316869

Total Area: 1,539,905

HbA1c (NGSP) = 5.7 %

20.0

17.5

15.0

12.5
%A1c

10.0
0.49

7.5
A1c -

0.78
0.22

0.39
0.16

5.0
0.86
-
-

-
-

2.5
1.00
-

0.0

0.00 0.25 0.50 0.75 1.00 1.25 1.50

Time (min.)

Page 3 of 5
 TEST REPORT Status : Final
Registration No. : 1056402396 Reg. Date : 28-May-2021 20:20 Collected On : 28-May-2021 20:20
Patient Name : Mr. NIKHIL GOYAL Approved on : 28-May-2021 22:00
Age : 30 Years Gender : Male Dispatch At :
Ref. By : Dr. RASESH DESAI Tele No. : 7600357698
Location : UHID / IPD : /

Test Name Results Units Bio. Ref. Interval

TESTOSTERONE

* TESTOSTERONE 9.06 ng/mL Prepubertal:

1-5 Mo 0.01-1.77
6-11 Mo 0.02-0.07
1-5 Yr 0.02-0.25
6-9 Yr 0.03-0.30
Pubertal: Tanner Stage
I <9.8 Yr 0.02-0.23
II 9.8-14.5 Yr 0.05-0.70
III 10.7-15.4 Yr 0.15-2.80
IV 11.8-16.2 Yr 1.05-5.45
V 12.8-17.3 Yr 2.65-8.00
Adult: 2.60-10.00
Method:CLIA

Uses of Testosterone:
1. Evaluation of men with symptoms or signs of possible hypogonadism.
2. Evaluation of boys with delayed/precocious puberty .
3. Evaluation of women with hirsuitism, virilization and oligo amenorrhoea.
4. Evaluationof women with symptoms/signs of possible testosterone deficiency.
5. Evaluation of infants with ambiguous genitalia/virilization.
6. Monitoring testosterone replacement therapy
7. Monitoring antiandrogen therapy.
VITAMIN B12
VITAMIN B12 L 177 pg/mL 211 - 911
Method:CLIA

Note: 
 
Dietary sources of Vitamin B12 are meat, eggs, milk and milk products. Vitamin B12 requires intrinsic factor for absorption from intestine. 
B12 deficiency causes hematological and neurological abnormalities. Decreased serum B12 levels causes increased excretion of methylmalonic acid. The
impaired DNA synthesis associated with Vitamin B12 deficiency causes macrocytic anemias. In sever is characterized by abnormal maturation of
erythrocyte, myeloid precursors and megakaryocytes in the bone marrow, which results in the pancytopenia.
Withhold Vitamin B12 injecion before the blood is drawn. Blood collected after Vitamin B12 Injection interfere with result. Preservatives such as fluorides &
ascorbic acid interfere with this assay. Excessive exposure of the specimen to light may alter Vitamin B12 result. 
To differentiate vitamin B12 & folate deficiency, measurement of Methyl malonic acid in urine & serum Homocysteine level is suggested.
 

This is an electronically authenticated report. Test done from collected sample.

Approved by: Dr. Vishal Jhaveri

Printed On: 29-May-2021 14:25 M.B.B.S, D.C.P
Reg. G-13041
Page 4 of 5
 TEST REPORT Status : Final
Registration No. : 1056402396 Reg. Date : 28-May-2021 20:20 Collected On : 28-May-2021 20:20
Patient Name : Mr. NIKHIL GOYAL Approved on : 28-May-2021 22:00
Age : 30 Years Gender : Male Dispatch At :
Ref. By : Dr. RASESH DESAI Tele No. : 7600357698
Location : UHID / IPD : /

VITAMIN D
25 OH Vitamin D Total 22.4 ng/mL Deficiency : <10
Insufficiency : 10 - 30
Sufficiency : 30 - 100
Toxicity : >100
Method:CLIA

Note:
 
Vitamin D is a fat soluble hormone involved in the intestinal absorption and deregulation of calcium. It is synthesized by skin when sunlight strikes bare skin.
It can also be ingested from animal sources. Vitamin D is bound to the binding protein (albumin and vitamin D binding protein) and carried to the liver. In the
liver it is transformed in to 25 hydroxy-vitamin D (calcidiol), which is the primary circulating and the most commonly measured form in serum. Then in the
kidney it is transformed in to 1,25 dihydroxy-vitamin D (calcitriol), which is the biologically active form.
Vitamin D plays a vital role in the formation and maintenance of strong and healthy bones. Vitamin D deficiency has long been associated with rickets in
children and osteomalacia in adults. Long term insufficiency of calcium and vitamin D leads to osteoporosis. There have been multiple publications linking
vitamin D deficiency to several disease states, such as cancer, cardiovascular disease, diabetes, and autoimmune diseases.
 
 
 

------------------ End Of Report ------------------

This is an electronically authenticated report. Test done from collected sample.

Approved by: Dr. Vishal Jhaveri

Printed On: 29-May-2021 14:25 M.B.B.S, D.C.P
Reg. G-13041
Page 5 of 5